Malignant Neoplasms of Urinary Tract Clinical Trials

11 clinical trials for Malignant Neoplasms of Urinary Tract across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases — RECRUITING · PHASE1
• Neurological adverse events in tumor patients receiving CAR-T-cells and immune checkpoint inhibitors: clinical and molecular patterns of toxicity effects — RECRUITING
• Developing a complementary medicine intervention tailored for cancer patients' healthcare needs to be addressed during follow-up care in general practice — RECRUITING
• Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT — ACTIVE_NOT_RECRUITING · PHASE1
• APTURO – Medication Reconciliation and Patient Information for Tumor Therapy in Uro-Oncology — OTHER
• Acquisition of optical and olfactory sensory impressions directly during radiation therapy with protons or photons — OTHER
• Oral Supplementation to Enhance Recovery Pilot Study — COMPLETED · PHASE1
• Neuromuscular Blockade on Shoulder Pain of Elderly — COMPLETED · PHASE4
• Investigation of Sugammadex in Outpatient Urological Procedures — COMPLETED · PHASE4
• Lenvatinib and Capecitabine in Patients With Advanced Malignancies — WITHDRAWN · PHASE1

Refine this search